Abstract
Introduction
IL-12, which is a disulfide-hnked heterodimeric cytokine consisting of 35 and 40 kDa subunits, has a capability of inducing IFN-y production and promoting Th1-dominant cellular immunity (1) (2) (3) . Although most cytokines have failed to show systemic immunomodulating activity in vivo because of their short half-life (4), IL-12 could modulate the cytokine network in vivo by a single systemic injection and showed a variety of immunoregulatory functions (5) (6) (7) (8) (9) (10) . Several animal models for tumor (7, 8) and infectious diseases (9, 10) have clearly demonstrated that IL-12 has a potent therapeutic effect in vivo through the activation of T h 1-dominant immunity which facilitates the generation of NK cells and cytotoxic T lymphocytes. However, it is also speculated that abnormal T h 1-T h 2 balances induced by IL-12 might accelerate the damage of autologous tissues mediated by cellular immunity. Indeed, recently, several investigators reported that in vivo administration of recombinant IL-12 accelerated graftversus-host reaction, Shwartzman reaction, septic shock and encephalomyelitis (EAE) autoimmune diseases (9) (10) (11) (12) (13) (14) It is an important issue to evaluate both the pros and cons of IL-12 administration in vivo for developing a suitable protocol for clinical application of IL-12.
In this paper, we investigated the role of IL-12 in T celldependent liver injury Although hepatitis represents a worldwide health problem in humans, little is known concerning the immunological mechanisms on the course of liver damage. This might be because of the absence of a suitable animal liver injury model resembling the clinical state of human hepatitis. To resolve this problem, we have tried to establish a T cell-dependent mouse liver injury model (15, 16) . It has been demonstrated that a heat-killed Gram-positive anaerobe, Propionibacterium acnes, which distributes in the liver longer than in the lung, kidney and spleen (17) , induced mouse liver injury by combination treatment with lipopolysaccharide (LPS) as well as Mycobactenum bovis BCG did (18) . Propionibacterium acnes and LPS-induced liver injury has been considered to be solely dependent on macrophages, which damage liver through the production of cytotoxic factors such as tumor necrosis factor-a (19) . However, the evidence described in our present and previous reports, demonstrated that T cells, especially T h 1 cells, were essential for the induction of final effector cells which were surrogated by P. acnes priming and LPS boosting, (i) Injection of P. acnes into mice caused a marked infiltration of both T cells and macrophages expressing high levels of LFA-1 molecules, and their infiltration was inhibited by the administration of anti-LFA-1 mAb in parallel with the inhibition of liver injury, (ii) Propionibacterium acnes and LPS-induced liver injury was not induced in athymic nude mice in contrast to euthymic mice, (iii) Propionibacterium acnes and LPS-induced liver injury was blocked by in vivo administration of anti-CD4 mAb or anti-IFN-ymAb. Using this model, it was clearly demonstrated that C57BL/6 mice and BALB/c mice showed different susceptibilities to T h 1-dependent mouse liver injury. Moreover, it was first demonstrated that IL-12 is a key cytokine in T h 1-dependent liver injury from the findings that in vivo administration of anti-IL-12 mAb blocked liver injury in sensitive C57BL/6 mice, while rlL-12 accelerated liver injury in resistant BALB/c mice.
Methods

Animals
C57BL/6 mice, BALB/c mice ICR (CRJ.CD1) mice, ICR nude mice and CB6F1 mice were purchased from Charles River Japan (Yokohama, Japan) and BALB.B mice were a kind gift of Dr T. Shiroyama (National Institute of Genetics, Mishima, Japan). All mice were used at 5-8 weeks of age T celltransferred ICR nude mice were prepared by i.v. infusion of nylon wool-passed ICR mouse spleen T cells (10 7 cells) into ICR nude mice just before P. acnes priming.
Induction of liver injury by P. acnes and LPS
Liver injury was induced in mice as described previously (15, 16) . Propionibacterium acnes was killed by culture in glycerol-free culture medium (GAM broth; Nissui Pharmaceutical, Tokyo, Japan) for 3 days at 37°C. To induce liver injury, the mice were treated with an i.v. injection of killed P. acnes (0.3 mg/mouse) suspended in 0.2 ml of saline unless otherwise indicated. Then the mice were given an i.v. injection of LPS (0.3 |ig/mouse) 7 days later. Injury to the liver was confirmed by measuring serum transaminase activities. Both aspartic acid transaminase (AST) and alanme transaminase (ALT) activities were determined using the AST, ALT test kit (Wako Pure Chemicals, Tokyo, Japan) and an autoanalyzer (Hitachi 7150). Briefly, 5 |il of each serum sample was incubated with 320 |il of L-alanine solution (for ALT) or Laspartic acid solution (for AST). After 5 min, 80 \i\ a-ketoglutaric acid solution was evaluated by UV absorption at 340 nm. Both ALT and AST units (IU/I) were calculated from the standard curve of NADH decrease.
Blocking of P. acnes and LPS-induced liver injury by in vivo administration of mAb
To characterize T cell subpopulations involved in P. acnes and LPS-induced liver injury, C57BL/6 mice were treated with i.p. injection of 500 ng/mouse of mAb against CD4 (RL-172 4) or CD8 (3.155) (kind gift of Dr N Minato, Kyoto University School of Medicine, Kyoto, Japan) (20) at days 0 or 1 before P acnes priming. Anti-IFN-y mAb (RA-6A2; PharMmgen, San Diego, CA) and anti-IL-12 mAb was i p. injected into the mice at days 0, 1 and 2 after P acnes priming. A mixture of two kinds of anti-IL-12 p40 mAb (C15.1 and C15.6 mAb, kindly donated by Dr G. Trinchieri, Wistar Institute of Anatomy and Biology, Philadelphia, PA) (13) was used for the experiment. As a control, the same amounts of rat lgG1 (PharMmgen) was i.p. injected into the mice.
Induction of P. acnes and LPS-induced liver injury by IL-12 administration
Recombinant mouse IL-12 (2000 U/mouse; kindly donated by Genetics Institute, Cambridge, MA) (21) was i.p. injected into the mice at days 0, 1, 2 and 3 after P. acnes priming As control, mice were treated with IL-12 alone or IL-12 plus LPS without P acnes priming.
Detection of cytokine activities
Serum IFN-y or IL-4 activities of the mice were measured at various days after P. acnes priming using an ELISA kit. The IFN-y activity was determined using the Endogen IFN-y ELISA kit (Endogen, Cambridge, MA) and IL-4 activity was determined using the Endogen IL-4 ELISA kit (Endogen). The mean of triplicate samples was as indicated in the data.
Histological studies
Livers were removed from the mice, and slices of the liver were fixed in 10% neutral formaline and embedded in paraffin. Individual section were examined after staining with hematoxylin and eosin.
RT-PCR
The spleen and liver tissues were obtained from C57BL/6 or BALB/c mice which were primed with P. acnes 7 days before the experiments. Total RNA was prepared from spleen or liver tissues using Trizol Reagent (Gibco/BRL, Grand Island, NY). Briefly, 5 (ig total RNA was incubated with oligo(dT) and reverse transcription was carried out using the Superscript Preamplification System (Gibco/BRL). The synthesized cDNA was amplified using LA PCR kit (Takara, Japan) in Gene Amp PCR System 9600 (Perkin-Elmer, Foster City, CA) for a total 30 cycles. Each cycle consisted of 1 min at 94°C, 1 min at 56°C and 2 min at 72°C. Oligonucleotides used for these analyses are as follows: IL-12 p40: forward primer 5'-CAGAAGCTAACCATCTCCTGGTTTG-3' and reverse primer 5'-TCCGGAGTAATTTGGTGCTTCACAC-3', IL-12 p35: forward primer 5'-CATGTGTCAATCACGCTACCTCCTC-3' and reverse primer 5'-TCCCACAGGAGGTTTCTGGCGCAGA-3', G3PDH: forward primer 5'-TGAAGGTCGGTGTGAACGG-ATTTGGC-3' and reverse primer 5'-CATGTAGGCCATG-AGGTCCACCAC-3'.
Results
CD4 + T cell-dependent mouse liver injury induced by P. acnes and LPS
Consistent with previous results (15, 16) , i.v injection of P acnes and LPS with a 7 day interval resulted in severe were treated with P acnes plus LPS over a 7 day interval as described in Methods (B) None, C57BL/6 mice were treated with saline, P acnes + LPS, C57BL/6 mice were treated with i.p injection of P acnes and then given an i.v injection of LPS, P. acnes + anti-CD4 mAb + LPS, C57BL/6 mice were treated with i.p injection of P acnes followed by anti-CD4 mAb treatment and then given an i v injection of LPS; P. acnes + anti-CD8 mAb + LPS, C57BL/6 mice were treated with i p injection of P. acnes followed by anti-CD8 mAb treatment and then given i v injection of LPS The serum ALT (hatched bars) and AST (solid bards) levels were determined 18 h after LPS treatment in both experiments The data represent mean ± SE of five mice damage of the liver and a marked elevation of serum ALT levels in ICR mice (Fig. 1A) . In contrast, athymic ICR nude mice developed no significant liver injury after P. acnes and LPS treatment. However, ICR nude mice, which were treated with cell transfer of splenic T cells, showed severe liver injury. These results clearly demonstrated that this liver injury model is T cell dependent. To evaluate which subpopulations of T cells are essential for this liver injury model, C57BL/6 mice were treated with mAb against CD4 or CD8 antigen before P. acnes priming. As shown in Fig 1(B) , P. acnes and LPS-induced liver injury was totally abrogated by in vivo administration of anti-CD4 mAb but not with anti-CD8 mAb. The inhibitory effect of anti-CD4 mAb is not derived from a non-specific effect of rat Ig because both anti-CD4 and anti-CD8 mAb are the same rat Ig isotype (IgM). From these results, we concluded that our established liver injury model is a CD4 + T cell-dependent mouse liver injury model.
The difference in susceptibility to liver injury between C57BLJ 6 and BALB/c mouse strains was closely associated with their different abilities to produce IFN-y after P. acnes priming
As shown in Fig. 2 , we found that there was a strain difference in the susceptibility to P. acnes and LPS-induced liver injury. In C57BL/6 mice, serum ALT activity was elevated dose dependently on P. acnes used for priming of the mice. In contrast, no significant increase of serum ALT level was shown in BALB/c mice. To evaluate the key cytokine which influences the susceptibility of the mice to liver injury, serum IFN-y activity of the mice primed with P. acnes was measured by ELISA.
As shown in Fig. 3 , the serum level of IFN-Y was significantly elevated in sensitive C57BL/6 mouse strains, whereas no increase of serum IFN-Y was detected at any time after P. acnes priming in resistant BALB/c strain. Although serum levels of IL-4 and IL-10 were also measured, no serum IL-4 and IL-10 activity was detected in both C57BL/6 and BALB/c mouse strains (data not shown). It was also demonstrated that P. acnes-primed C57BL/6 mouse spleen T cells, but not BALB/c mouse spleen cells, produced IFN-Y by in vitro restimulation with P. acnes, and the production was blocked by the depletion of CD4 + T cells (data not shown). These results suggested that the different serum IFN-y levels induced by P. acnes priming might be associated with the susceptibility of the mice to P acnes and LPS-induced liver injury. To determine whether IFN-Y induced by priming with P. acnes is an essential factor for liver injury, C57BL/6 mice were treated with anti-IFN-Y mAb or control rat lgG1. The elevated serum transaminase activity was decreased to control levels when C57BL/6 mice were i.p. treated with anti-IFN-y mAb at days 0, 1 and 2 after P. acnes treatment (Fig. 4) . Moreover, 5000 r Fig. 3 . Difference in ability to produce IFN-Y between C57BL/6 and BALB/c mice after priming with P acnes C57BL/6 mice (solid circles) and BALB/c mice (open circles) were treated with i.p injection of P acnes At various days after P acnes treatment, serum IFN-Y activity was determined using ELISA The data represent mean ± SE of five mice 2 3 4 Treated mice Fig. 4 . Blocking of P acnes and LPS-mduced liver injury by in vivo administration of anti-IFN-y mAb. C57BL/6 mice were treated with various conditions and then their serum ALT levels were measured 18 h after LPS treatment Bar 1, untreated C57BL/6 mice, bar 2, C57BL/6 mice treated with P acnes plus LPS, bar 3, C57BL/6 mice treated with P acnes, anti-IFN-y mAb and LPS, bar 4, C57BL/6 mice treated with P acnes, rat lgG1 and LPS The data represent mean ± SE of five mice in vivo administration of recombinant IFN-Y with P. acnes into BALB/c mice caused a partial induction of liver injury after LPS treatment (data not shown). From these data, IFN-Y production induced by priming with P. acnes is demonstrated to be essential for the induction of P. acnes and LPSinduced severe liver injury. Thus, our established model was demonstrated to be a T h 1-dependent liver injury model.
IL-12 is a key cytokine in T h 1-dependent liver injury
In vivo administration of IL-12 into the mice resulted in an elevation of serum IFN-Y activity in both sensitive C57BL/6 mice and resistant BALB/c mice 24 h after treatment (data not shown). If BALB/c mice were resistant to P. acnes and LPS-induced liver injury because of the absence of P. acnesinduced IFN-y production, in vivo administration of IL-12 with P. acnes might induce liver injury even in resistant BALB/c mice. As expected, BALB/c mice treated with P. acnes, IL-12 and LPS showed severe liver injury (Fig. 5) . However, treatment of the mice with IL-12 alone or IL-12 plus LPS showed no significant effect on the induction of liver injury. In parallel with the induction of liver injury, the serum levels of IFN-Y were markedly elevated in BALB/c mice treated with P. acnes plus IL-12 (3759 ± 250 pg/ml) compared with mice treated with P. acnes alone (0 pg/ml). These data demonstrated that exogenously administered IL-12 has a capability of inducing T^1-dominant immunity which accelerated liver injury even in the normally resistant BALB/c mouse strain.
To evaluate whether endogenously produced IL-12 is involved in P. acnes and LPS-induced liver injury, the effect of anti-IL-12 mAb on liver injury was investigated using the sensitive C57BL/6 mouse strain. As shown in Fig. 6 , administration of anti-IL-12 mAb at days 0,1 and 2 after P. acnes treatment almost completely abrogated the elevation of serum ALT and AST activity Such inhibition was not demonstrated by control rat lgG1. The elevation of serum levels of IFN-Y by priming with P acnes (1216 ± 180 pg/ml) was also blocked by the administration of anti-IL-12 mAb (43 ± 26 pg/ml). These data clearly demonstrate that endogenously produced IL-12 after P. acnespriming is involved in Th 1 -dependent liver injury induced by P. acnesand LPS through the stimulation of IFN-yproduction. As shown in Fig. 7 , the accelerating effect of IL-12 on liver injury in BALB/c (Fig. 7F ) and inhibitory effect of anti-IL-12 mAb on liver injury in C57BL/6 mice (Fig. 7C) were also demonstrated by histological analyses.
Finally, we investigated the strain difference of IL-12 production between C57BL/6 mice and BALB/c mice. The expression of IL-12 p40 and p35 mRNA were determined by RT-PCR using the liver and spleen obtained from P. acnes-primed C57BL/6 or BALB/c mice. As clearly demonstrated in Fig. 8 , no significant differences of IL-12 p40 and p35 mRNA expression were demonstrated between the spleen of C57BL/6 and BALB/ c mice after priming with P. acnes However, in the liver, high expression of both IL-12 p40 and P35 mRNA was detected in C57BL/6 but not in BALB/c mice. The same results were confirmed by four different experiments. In the BALB/c mouse liver, a faint band of IL-12 p40 was detected on the gel (but invisible in a photograph) in three out of four experiments but no IL-12 p35 expression was demonstrated in any experiment. Thus, we concluded that the production of functional IL-12 may be defective in BALB/c mice at the local site of liver, in contrast to C57BL/6 mice.
Discussion
In this paper, we demonstrate that P. acnes and LPS-induced mouse liver injury is dependent on CD4 + T cells. Moreover, IFNyproduction of the mice primed with P. acnes is demonstrated to be essential for the induction of liver injury from the evidence that in vivo administration of anti-IFN-Y mAb abrogated the elevation of serum ALT and AST activities. Therefore, the liver injury model described herein is characterized as T h 1 -dependent liver injury model.
Recent work (22, 23) has demonstrated that T h 1 cells, which . Anti-IL-12 mAb blocked P. acnes and LPS-induced liver injury. Propionibacterium acnes and LPS-induced liver injury was induced in C57BL/6 mice as described in the legend to Fig. 1 . Bar 1, untreated mice; bar 2, mice treated with P. acnes plus LPS; bar 3, mice treated with P acnes, anti-IL-12 mAb and LPS injection; bar 4, mice treated with P. acnes and rat lgG1 and then LPS injection. Serum ALT activity was measured at 18 h after LPS injection The data represent mean ± SE of five mice produce IFN-y and IL-2, stimulate cell-mediated immunity. In contrast, 1^2. cells, which produce IL-4 and IL-5, play an important role in humoral immunity. The T h 1-Th2 balance appears to be a key factor which determines healing or progression of some infectious diseases (24) (25) (26) . In general, IFN-y-producing T h 1 cells necessaryfor control of infection are present in healing tissues, whereas progression of diseases is mediated by 1^2. CD4 + T cells. Interestingly, it is also demonstrated that BALB/ c mice, which show Th2-dominant immunity after infection with Leishmania major, are susceptible to cutaneous infection, while C57BL/6 mice, showing T h 1-dominant immunity, are resistant to L. major infection (24) . Conversely to this, in this paper, we demonstrate that C57BL/6 mice are susceptible to P. acnes and LPS-induced liver injury, but BALB/c mice are resistant to the liver injury. Recently both MHC-linked and non-MHC genes were demonstrated to be responsible for the regulation of T h 1-T h 2 balances (27) (28) (29) . We have evidence that CB6F1 (H-2^d) and BALB.B congeneic mice (H-2 b ) were sensitive to liver injury as well asC57BL/6 mice (H-2 b ) and B10 (H-2 b ), but B10D2 (H-2 d ) were also sensitive to liver injury in contrast to BALB/c (H- 2^) (data not shown). Therefore, the difference in susceptibility to T h 1-dependent liver injury between C57BL/6 and BALB/c appeared to be regulated by a non-MHC gene-coded unknown factor. The difference in susceptibility between C57BL/6 mice and BALB/c mice is closely correlated with their different abilities to produce IFN-y after priming with P. acnes. C57BL/6 mice produce high levels of IFN-y 7-10 days after priming with P. acnes, while BALB/c mice do not produce IFN-yat any days tested. The absence of IFN-yproduction in BALB/c mice primed with P. acnes may be a main cause of the failure to induce liver injury by P. acnes plus LPS. This hypothesis is supported, by the finding that in vivo administration of IL-12, which has been demonstrated to stimulate IFN-y production of T h 1 and NK cells in vivo (5) , elicits severe liver injury even in resistant BALB/c mice in combination with P. acnes and LPS treatment (Fig. 5) . The detailed mechanisms of IL-12-induced liver injury in P. acnes plus LPS-treated BALB/c mice remains unclear. However, this may involve the induction of P. acnes-specific IFN-y producing T h 1 cells by IL-12 because non-specific activation of T cells, NK cells or macrophages with IL-12 alone or IL-12 plus LPS in the absence of P. acnes priming shows no significant effect on inducing liver injury. The importance of endogenously produced IL-12 in the liver injury is also demonstrated using anti-IL-12 mAb. As shown in Fig. 6 , in vivo administration of anti-IL-12 mAb with P. acnes caused total inhibition of liver injury. Judging from the evidence that liver injury is abrogated by in vivo administration of anti-CD4, anti-IFN-yor anti-IL-12 mAb, activation of IFN-y-producing T h 1 cells, which is initiated by IL-12, appeared to be essential for sequential immune responses on the course of T cell-dependent liver injury induced by P. acnes plus LPS. The key role of IL-12 is also suggested from a finding that the failure of induction of liver injury in BALB/c mice appears to be derived from the lack of functional IL-12 expression in the local site of liver in P. acnesprimed mice (Fig 8) . This result is supported by recent evidence that antigen-driven IL-12 production by antigen-presenting cells was lower in BALB/c compared with other mouse strains (30) . The differential expression pattern of IL-12 p35 and p40 mRNA in the liver and spleen is not inconsistent with recent findings that IL-12 p35 and p40 expression appeared to be differentially regulated among heterogenous cell populations in the spleen (31) . Taken together these results suggest that priming of susceptible C57BL/6 mice with P. acnes results in the elevation of endogenous IL-12 production at the site of liver where a heat-killed P. acnes distribute for a longer time Fig. 8 . Propionibactenum acnes priming induced IL-12 p35 and p45 mRNA expression in the liver of C57BL/6 mice but not in BALB/c mice Total RNA was prepared from spleen (A and B) or liver (C and D) tissues and RT-PCR was carried out using the Gene Amp PCR System 9600 (Perkm-Elmer) as described in Methods (A) IL-12 p40 or G3PDH mRNA expression in the spleen obtained from untreated BALB/c mouse (1), P acnes-primed BALB/c mice (2), untreated C57BL76 mice (3) or P acnes-primed C57BL/6 mice (4) (B) IL-12 p35 mRNA expression in the spleen obtained from untreated BALB/c mouse (5), P acnes-primed BALB/c mice (6), untreated C57BL/6 mice (7) or P acnes-primed C57BL/6 mice (8) (C) IL-12 p40 or G3PDH mRNA expression in the liver obtained from untreated BALB/c mouse (9 and 10), P acnes-primed BALB/c mice (11 and 12) , untreated C57BL/6 mice (13 and 14) or P acnes-primed C57BL/6 mice (15 and 16) (D) IL-12 p35 mRNA expression in the liver obtained from untreated BALB/c mouse (17 and 18), P acnes-primed BALB/c mice (19 and 20) , untreated C57BL/6 mice (21 and 22) or P acnes-primed C57BL/6 mice (23 and 24) (17) , and then IFN-y production of liver-infiltrating T h 1 cells is stimulated by IL-12. Such T h 1 -dominant immunity may also facilitate the activation of CD8 + killer T cells or preactivation of macrophages LPS have been demonstrated to stimulate B cells and macrophages. However, recently, LPS was also demonstrated to stimulate IFN-y production by NK and T cells through the induction of IL-12 production by macrophages (14) . Moreover, the effect of LPS on TNF-a and IL-12 production by macrophages is markedly enhanced by pretreatment with IFN-Y (3)-Therefore, the final boosting with LPS of P. acnesprimed C57BL/6 mice may cause a strong stimulation of both liver-infiltrating macrophages and T cells, which were preactivated with T h 1 -derived IFN-y, and triggers the liver injury through cytokine (i e tumor necrosis factor-a)-mediated (18) and/or cell-mediated lysis.
I I
Because T cell-mediated immune responses have been demonstrated to be involved in human hepatitis (32, 33) , it is an important issue to establish a T cell-dependent liver injury model and investigate its relevance to human hepatitis. Four T cell-mediated liver injury models (16, (34) (35) (36) (37) have been reported to date. However, our liver injury model described herein may be a suitable model to investigate the role of T h 1-dommant immunity in liver injury and the factors which influence the susceptibility of liver injury. In human hepatitis, it is well known that some patients show acute liver damage and others show a chronic state. This might be also correlated with the different T h 1-T h 2 balance in hepatitis patients.
Finally, our findings that in vivo administration of IL-12 with some immunostimulants (P. acnes and LPS) caused induction of liver injury in BALB/c mice, which were originally resistant to liver injury, provide some warning that clinical application of IL-12 to patients with severe infection may induce unexpected liver damage Further detailed studies concerning in vivo biological functions of IL-12 may provide an ideal protocol for clinical application of IL-12 for immunotherapy of tumors or infectious diseases. AST aspartic acid transammase LPS lipopolysacchande
